Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 5-6, 2010, Pages 581-586

  Li, Yong Jian ^a,c   Rha, Seung Woon ^a   Chen, Kang Yin ^c   Jin, Zhe ^c   Minami, Yoshiyasu ^a   Wang, Lin ^a   Dang, Qun ^c   Poddar, Kanhaiya L ^a   Ramasamy, Sureshkumar ^a   Park, Ji Young ^a   Oh, Dong Joo ^a   Jeong, Myung Ho ^b  

^a Korea University Ansan Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Drug eluting stent; Percutaneous coronary intervention; Prior cerebrovascular disease

Indexed keywords

ANTICOAGULANT AGENT;

ACUTE HEART INFARCTION; AGE; AGED; ARTICLE; ASIAN; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HEART DEATH; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE; CEREBROVASCULAR DISORDERS; CLINICAL TRIAL; COMPLICATION; FIBRINOLYTIC THERAPY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; REGISTER; SOUTH KOREA; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CEREBROVASCULAR DISORDERS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; SEX FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 77951122419     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05363.x     Document Type: Article

References (13)

1. Cragg DR, Friedman HZ, Bonema JD et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann. Intern. Med. 1991 115 : 173 177.
2. Pfeffer MA, Moye LA, Braunwald E et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA 1991 266 : 528 532.
3. Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham Study. Am. Heart J. 1993 125 : 863 872.
4. Ketley D, Woods KL. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: A population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group. Br. Heart J. 1995 74 : 224 228.
5. Tanne D, Gottlieb S, Caspi A et al. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: The Israeli Thrombolytic National Survey. Arch. Intern. Med. 1998 158 : 601 606.
6. Cotter G, Cannon CP, McCabe CH et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes - Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am. Heart J. 2003 145 : 622 627.
7. Hasdai D, Haim M, Behar S, Boyko V, Battler A. Acute coronary syndromes in patients with prior cerebrovascular events. Lessons from the Euro-Heart Survey of Acute Coronary Syndromes. Am. Heart J. 2003 146 : 832 838. (Pubitemid 37378572)
8. Cooper HA, Domanski MJ, Rosenberg Y et al. Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial. Am. Heart J. 2004 148 : 1012 1019.
9. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 110 : e82 292.
10. Smith SC Jr., Feldman TE, Hirshfeld JW Jr. et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006 113 : 156 175.
11. Luscher TF, Steffel J, Eberli FR et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007 115 : 1051 1058.
12. Park DW, Park SW, Park KH et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am. J. Cardiol. 2006 98 : 352 356.
13. Daemen J, Wenaweser P, Tsuchida K et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007 369 : 667 678.